NEUROPHET

About:

NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment.

Website: http://www.neurophet.com

Top Investors: TIPS Program, Mirae Asset Securities, SBI Investment, FuturePlay, Industrial Bank of Korea

Description:

Neurophet produces solutions based on Segengine, the company’s own technology that automatically segments brain magnetic resonance (MR) images into 107 regions within a minute.

Total Funding Amount:

48B KRW

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Gangneung, Kangwon-do, South Korea

Founded Date:

2016-03-14

Founders:

Donghyeon Kim, Junkil Been

Number of Employees:

51-100

Last Funding Date:

2023-11-07

IPO Status:

Private

© 2024 MyAiNote.com